The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Small-Molecule Antiviral β- d - N 4 -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
Open accessAbstract
The emergence of coronaviruses (CoVs) into human populations from animal reservoirs has demonstrated their epidemic capability, pandemic potential, and ability to cause severe disease. However, no antivirals have been approved to treat these infections. Here, we demonstrate the potent antiviral activity of a broad-spectrum ribonucleoside analogue, β- d - N 4 -hydroxycytidine (NHC), against two divergent CoVs. Viral proofreading activity does not markedly impact sensitivity to NHC inhibition, suggesting a novel interaction between a nucleoside analogue inhibitor and the CoV replicase. Further, passage in the presence of NHC generates only low-level resistance, likely due to the accumulation of multiple potentially deleterious transition mutations. Together, these data support a mutagenic mechanism of inhibition by NHC and further support the development of NHC for treatment of CoV infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3653 · Cited by 1,571
Self-citationTherapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., et al. (2016) · Nature · doi:10.1038/nature17180 · Cited by 1,556
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., et al. (2018) · mBio · doi:10.1128/mbio.00221-18 · Cited by 1,416
Self-citationWilm, A., Aw, P. P. K., Bertrand, D., Yeo, G. H. T., Ong, S. H., Wong, C. H., Khor, C. C., Petric, R., Hibberd, M. L., & Nagarajan, N. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks918 · Cited by 1,372
Sanjuán, R., Nebot, M. R., Chirico, N., Mansky, L. M., & Belshaw, R. (2010) · Journal of Virology · doi:10.1128/jvi.00694-10 · Cited by 1,246
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
Jordheim, L. P., Durantel, D., Zoulim, F., & Dumontet, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4010 · Cited by 1,211
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Scaling read aligners to hundreds of threads on general-purpose processors
Langmead, B., Wilks, C., Antonescu, V., & Charles, R. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty648 · Cited by 942
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Menachery, V. D., Yount, B. L., Debbink, K., Agnihothram, S., Gralinski, L. E., Plante, J. A., Graham, R. L., Scobey, T., Ge, X.-Y., Donaldson, E. F., et al. (2015) · Nature Medicine · doi:10.1038/nm.3985 · Cited by 901
Self-citationGaunt, E. R., Hardie, A., Claas, E. C. J., Simmonds, P., & Templeton, K. E. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00636-10 · Cited by 699
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Warren, T. K., Wells, J., Panchal, R. G., Stuthman, K. S., Garza, N. L., Van Tongeren, S. A., Dong, L., Retterer, C. J., Eaton, B. P., Pegoraro, G., et al. (2014) · Nature · doi:10.1038/nature13027 · Cited by 610
Sequence-specific error profile of Illumina sequencers
Nakamura, K., Oshima, T., Morimoto, T., Ikeda, S., Yoshikawa, H., Shiwa, Y., Ishikawa, S., Linak, M. C., Hirai, A., Takahashi, H., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr344 · Cited by 600
Smith, E. C., Blanc, H., Vignuzzi, M., & Denison, M. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003565 · Cited by 444
Self-citationSARS-like WIV1-CoV poised for human emergence
Menachery, V. D., Yount, B. L., Sims, A. C., Debbink, K., Agnihothram, S. S., Gralinski, L. E., Graham, R. L., Scobey, T., Plante, J. A., Royal, S. R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517719113 · Cited by 418
Self-citationStructural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA
Ferron, F., Subissi, L., Silveira De Morais, A. T., Le, N. T. T., Sevajol, M., Gluais, L., Decroly, E., Vonrhein, C., Bricogne, G., Canard, B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718806115 · Cited by 404
Antivirals and antiviral strategies
Clercq, E. D. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro975 · Cited by 370
Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus
Anthony, S. J., Gilardi, K., Menachery, V. D., Goldstein, T., Ssebide, B., Mbabazi, R., Navarrete-Macias, I., Liang, E., Wells, H., Hicks, A., et al. (2017) · mBio · doi:10.1128/mbio.00373-17 · Cited by 357
Self-citationBouvet, M., Imbert, I., Subissi, L., Gluais, L., Canard, B., & Decroly, E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201130109 · Cited by 345
High Fidelity of Murine Hepatitis Virus Replication Is Decreased in nsp14 Exoribonuclease Mutants
Eckerle, L. D., Lu, X., Sperry, S. M., Choi, L., & Denison, M. R. (2007) · Journal of Virology · doi:10.1128/jvi.01296-07 · Cited by 332
Self-citationSystematic Assembly of a Full-Length Infectious cDNA of Mouse Hepatitis Virus Strain A59
Yount, B., Denison, M. R., Weiss, S. R., & Baric, R. S. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.11065-11078.2002 · Cited by 324
Self-citationYang, Y., Du, L., Liu, C., Wang, L., Ma, C., Tang, J., Baric, R. S., Jiang, S., & Li, F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405889111 · Cited by 281
Self-citationMERS Coronavirus in Dromedary Camel Herd, Saudi Arabia
Hemida, M. G., Chu, D. K. W., Poon, L. L. M., Perera, R. A. P. M., Alhammadi, M. A., Ng, H.-Y., Siu, L. Y., Guan, Y., Alnaeem, A., & Peiris, M. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2007.140571 · Cited by 278
Spread, Circulation, and Evolution of the Middle East Respiratory Syndrome Coronavirus
Cotten, M., Watson, S. J., Zumla, A. I., Makhdoom, H. Q., Palser, A. L., Ong, S. H., Al Rabeeah, A. A., Alhakeem, R. F., Assiri, A., Al-Tawfiq, J. A., et al. (2014) · mBio · doi:10.1128/mbio.01062-13 · Cited by 266
Arabi, Y. M., Shalhoub, S., Mandourah, Y., Al-Hameed, F., Al-Omari, A., Al Qasim, E., Jose, J., Alraddadi, B., Almotairi, A., Al Khatib, K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz544 · Cited by 248
Yoon, J.-J., Toots, M., Lee, S., Lee, M.-E., Ludeke, B., Luczo, J. M., Ganti, K., Cox, R. M., Sticher, Z. M., Edpuganti, V., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-18 · Cited by 236
Self-citationThe contribution of epistasis to the architecture of fitness in an RNA virus
Sanjuán, R., Moya, A., & Elena, S. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404125101 · Cited by 233
Sexton, N. R., Smith, E. C., Blanc, H., Vignuzzi, M., Peersen, O. B., & Denison, M. R. (2016) · Journal of Virology · doi:10.1128/jvi.00080-16 · Cited by 209
Self-citationSEROEPIDEMIOLOGIC STUDIES OF CORONAVIRUS INFECTION IN ADULTS AND CHILDREN1
MCINTOSH, K., KAPIKIAN, A. Z., TURNER, H. C., HARTLEY, J. W., PARROTT, R. H., & CHANOCK, R. M. (1970) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121171 · Cited by 200
Stuyver, L. J., Whitaker, T., McBrayer, T. R., Hernandez-Santiago, B. I., Lostia, S., Tharnish, P. M., Ramesh, M., Chu, C. K., Jordan, R., Shi, J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.244-254.2003 · Cited by 199
Graham, R. L., Sims, A. C., Brockway, S. M., Baric, R. S., & Denison, M. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13399-13411.2005 · Cited by 192
Self-citationUrakova, N., Kuznetsova, V., Crossman, D. K., Sokratian, A., Guthrie, D. B., Kolykhalov, A. A., Lockwood, M. A., Natchus, M. G., Crowley, M. R., Painter, G. R., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01965-17 · Cited by 192
Self-citationClinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations
Walsh, E. E., Shin, J. H., & Falsey, A. R. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit393 · Cited by 182
Derse, D., Cheng, Y. C., Furman, P. A., St Clair, M. H., & Elion, G. B. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68420-6 · Cited by 180
Control Measures for Severe Acute Respiratory Syndrome (SARS) in Taiwan
Twu, S.-J., Chen, T.-J., Chen, C.-J., Olsen, S. J., Lee, L.-T., Fisk, T., Hsu, K.-H., Chang, S.-C., Chen, K.-T., Chiang, I.-H., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0906.030283 · Cited by 179
Clinical management and infection control of SARS: Lessons learned
Cheng, V. C., Chan, J. F., To, K. K., & Yuen, K. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.016 · Cited by 176
Potential antivirals and antiviral strategies against SARS coronavirus infections
De Clercq, E. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.2.291 · Cited by 176
A time-of–drug addition approach to target identification of antiviral compounds
Daelemans, D., Pauwels, R., Clercq, E. D., & Pannecouque, C. C. (2011) · Nature Protocols · doi:10.1038/nprot.2011.330 · Cited by 150
Barnard, D. L., Hubbard, V. D., Burton, J., Smee, D. F., Morrey, J. D., Otto, M. J., & Sidwell, R. W. (2004) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020401500102 · Cited by 150
Inhibition of Human Coronavirus NL63 Infection at Early Stages of the Replication Cycle
Pyrć, K., Bosch, B., Berkhout, B., Jebbink, M. F., Dijkman, R., Rottier, P. J. M., & van der Hoek, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01598-05 · Cited by 131
Evolution favors protein mutational robustness in sufficiently large populations
Bloom, J. D., Lu, Z., Chen, D., Raval, A., Venturelli, O. S., & Arnold, F. H. (2007) · BMC Biology · doi:10.1186/1741-7007-5-29 · Cited by 119
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
Eltahla, A. A., Luciani, F., White, P. A., Lloyd, A. R., & Bull, R. A. (2015) · Viruses · doi:10.3390/v7102868 · Cited by 115
Mutation and Epistasis in Influenza Virus Evolution
Lyons, D. M., & Lauring, A. S. (2018) · Viruses · doi:10.3390/v10080407 · Cited by 115
Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
Reynard, O., Nguyen, X.-N., Alazard-Dany, N., Barateau, V., Cimarelli, A., & Volchkov, V. E. (2015) · Viruses · doi:10.3390/v7122934 · Cited by 112
Chen, W., & Baric, R. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3947-3960.1996 · Cited by 103
Self-citationCharacterization of β- d - N 4 -Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus
Ehteshami, M., Tao, S., Zandi, K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02395-16 · Cited by 101
Schwarz, B., Routledge, E. G., & Siddell, S. G. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4784-4791.1990 · Cited by 93
Antiviral drugs specific for coronaviruses in preclinical development
Adedeji, A. O., & Sarafianos, S. G. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.06.002 · Cited by 89
Deval, J. (2009) · Drugs · doi:10.2165/00003495-200969020-00002 · Cited by 86
Pathways to extinction: beyond the error threshold
Manrubia, S. C., Domingo, E., & Lázaro, E. (2010) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0076 · Cited by 77
Antiviral Activity of Nucleoside Analogues against Norovirus
Costantini, V., Whitaker, T., Barclay, L., Lee, D. M., McBrayer, T. R., Schinazi, R. F., & Vinjé, J. (2012) · Antiviral Therapy · doi:10.3851/imp2229 · Cited by 73
Cell-Type-Specific Type I Interferon Antagonism Influences Organ Tropism of Murine Coronavirus
Zhao, L., Rose, K. M., Elliott, R., van Rooijen, N., & Weiss, S. R. (2011) · Journal of Virology · doi:10.1128/jvi.05075-11 · Cited by 73
Graepel, K. W., Lu, X., Case, J. B., Sexton, N. R., Smith, E. C., & Denison, M. R. (2017) · mBio · doi:10.1128/mbio.01503-17 · Cited by 73
Self-citationBalkhy, H. H., Alenazi, T. H., Alshamrani, M. M., Baffoe-Bonnie, H., Arabi, Y. M., Hijazi, R., Al-Abdely, H. M., El‐Saed, A., Johani, S. A., Assiri, A. M., et al. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2016.132 · Cited by 69
Growth and Quantification of MERS‐CoV Infection
Coleman, C. M., & Frieman, M. B. (2015) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc15e02s37 · Cited by 66
The origins of mutational robustness
Fares, M. A. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.04.008 · Cited by 64
Biktasova, A., Hajek, M., Sewell, A. K., Gary, C. S., Bellinger, G., Deshpande, H. A., Bhatia, A. K., Burtness, B. A., Judson, B. L., Mehra, S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1438 · Cited by 59
Control of an Outbreak of Middle East Respiratory Syndrome in a Tertiary Hospital in Korea
Park, G. E., Ko, J., Peck, K. R., Lee, J. Y., Lee, J., Cho, S. Y., Ha, Y. E., Kang, C., Kang, J., Kim, Y., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2495 · Cited by 57
Theories of Lethal Mutagenesis: From Error Catastrophe to Lethal Defection
Tejero, H., Montero, F., & Nuño, J. C. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_463 · Cited by 28
Cited by
Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients.
Jayk Bernal, A., Gomes da Silva, M. M., Musungaie, D. B., Kovalchuk, E., Gonzalez, A., Delos Reyes, V., Martín-Quirós, A., Caraco, Y., Williams-Diaz, A., Brown, M. L., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2116044 · Cited by 1,857
Sheahan, T. P., Sims, A. C., Zhou, S., Graham, R. L., Pruijssers, A. J., Agostini, M. L., Leist, S. R., Schäfer, A., Dinnon, K. H., Stevens, L. J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb5883 · Cited by 1,071
Self-citationStructural Basis for RNA Replication by the SARS-CoV-2 Polymerase
Wang, Q., Wu, J., Wang, H., Gao, Y., Liu, Q., Mu, A., Ji, W., Yan, L., Zhu, Y., Zhu, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.034 · Cited by 776
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Kabinger, F., Stiller, C., Schmitzová, J., Dienemann, C., Kokic, G., Hillen, H. S., Höbartner, C., & Cramer, P. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00651-0 · Cited by 750
Malone, B., Urakova, N., Snijder, E. J., & Campbell, E. A. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00432-z · Cited by 530
Metadata
- Authors
- Agostini, M. L., Pruijssers, A. J., Chappell, J. D., Gribble, J., Lu, X., Andres, E. L., Bluemling, G. R., Lockwood, M. A., Sheahan, T. P., Sims, A. C., Natchus, M. G., Saindane, M., Kolykhalov, A. A., Painter, G. R., Baric, R. S., & Denison, M. R.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2019-12
- Volume
- 93
- Issue
- 24
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2979108578
- Cited by
- 337
- References
- 64
- FWCI
- 35.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.